The meal vouchers & employee benefits solutions market size was valued at USD 214.36 billion in 2022 and is projected to grow from USD 221.99 billion in 2023 to USD 346.65 billion by 2030, exhibiting a CAGR of 6.6% during the forecast period. This information is published by Fortune Business Insights, in its report titled, “Meal Vouchers & Employee Benefits Solutions Market, 2023-2030”.
List of Key Players Profiled in the Meal Vouchers & Employee Benefits Solutions Market Report:
- Edenred SA (France)
- Sodexo Group (France)
- Circula GmbH (Germany)
- CIRFOOD (Italy)
- Monizze NV SA (Belgium)
- Spendit AG (Germany)
- Alelo Brasil (Brazil)
- Axis Bank Ltd (India)
- Rakuten Group Inc. (Japan)
- Unum Group (U.S.)
- Cinqo Group (Bahrain)
Report Coverage:
The research report provides a detailed analysis of the market and focuses on crucial aspects such as leading companies and product types. Besides, the report encompasses the latest market trends, market segments, and highlights vital industry developments. In addition to the factors mentioned above, the market analysis encompasses several factors that have contributed to the market’s growth in recent years.
Drivers and Restraints:
Growing Awareness of Financial Benefits to Boost Market Growth
The meal voucher system is profitable for both employees and employers as it has several fiscal benefits. Employers' social insurance changes can be waived if they offer a voucher, and the employee can enjoy tax benefits by using these vouchers. Additionally, such programs have proved to increase employee productivity due to superior quality meals and other advantages offered such as discounts on train/bus tickets or gift vouchers and holidays. Consequently, employers play a vital role in boosting employee engagement at their workplace and presenting benefits that will accelerate the meal vouchers & employee benefits solutions market growth.
However, the high prices of meal vouchers & employee benefits solutions might restrict their demand among small-sized enterprises. Furthermore, data security concerns with respect to using digital meal vouchers might also limit the demand for meal voucher solutions.
Segments:
Employee Benefits Segment to Lead due to High Demand from Business Organizations
Based on product type, the market is segmented into meal vouchers and employee benefits. The employee benefits segment is expected to hold a dominating meal vouchers & employee benefits market share as organizations are increasingly demanding employee benefits solutions to satisfy their employees’ needs and improve their purchasing power and motivation level.
The global market is analyzed across North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
Regional Insights:
Europe Market to Show Notable Growth Due to Supportive Government Policies
Europe is predicted to capture the largest meal vouchers & employee benefits solutions market share as the regional governments are introducing favorable policies to promote the implementation of meal vouchers and employee benefits solutions. Many leading players in this market are trying to expand their presence across Europe by acquiring the region’s top employee benefit solution providers. These factors will fuel the regional market growth.
The North America market is anticipated to account for a major market share during the forecast period as the region has a vast presence of leading employee benefit solution providers. Many American companies are also becoming aware of employee perks, further accelerating the regional market expansion.
Competitive Landscape:
Key Companies to Execute Merger & Acquisition Strategies to Cement Their Market Positions
The top companies involved in the market are focusing on expanding their business operations by signing merger & acquisition agreements to cement their market positions. For example, in May 2020, Edenred announced the acquisition of Brazil-based Cooper Card’s client portfolio, which specializes in offering employee benefits solutions. The acquisition was expected to strengthen Edenred’s position in the South America market. These initiatives will help the leading market players expand their geographical presence.
Key Industry Developments:
- October 2021: Edenred Benefits, a prominent meal vouchers & employee advantages solutions in the U.S for meal cards and mobility solutions, introduced ‘Edenred Guaranteed Rides’, a program that offers employees a wide range of transportation choices.
Browse Detailed Summary of Research Report:
https://www.fortunebusinessinsights.com/meal-voucher-and-employee-benefit-solutions-market-104412
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Research study on Global Sweeteners and Sweetening Solutions Market - Examination of Market Segmentation Including Product Type, Application, And RegionsFior Markets has declared the addition of a new research report titled Global Sweeteners and Sweetening Solutions Market which is all around made by considering its essential information in the overall global Sweeteners and Sweetening Solutions market.
The report focuses on the market trends, demand spectrum, and future prospects of this industry over the forecast period from 2019-2024.
The report offers a detailed statistical overview of product scope, market overview, geographical opportunities, restraints, drivers, market risk, market driving force.
Our best experts have surveyed the market report with the reference of inventories and data given by the key players.DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report/global-sweeteners-and-sweetening-solutions-market-growth-2019-2024-391334.html#sample Market Anlaysis:The report studies top manufacturer/players with their sales, revenue, and price, in 2018 and 2019 followed by regions and country-wise analysis of sales, revenue and market share.
The report presents the latest industry data and future trends that will help you recognize the products and end users driving revenue growth and profitability of the market.
It provides an assessment of the report from the reader’s accurate statistics and analytical data in a simple manner by means of graphs, diagrams, pie charts, and other pictorial illustrations.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
